Regado Biosciences, Inc RGDO Securities Lawsuit

Company:	Regado Biosciences, Inc
Ticker Symbol:	RGDO
Class Period:	Aug-22-13 to Jul-2-14
Date Filed:	Sep-3-14
Lead Plaintiff Deadline:	Nov-2-14
Court:	District of New Jersey
Allegations:

Los Angeles, CA: A securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Regado Biosciences, Inc. ("Regado"or the "Company") (NasdaqCM: RGDO) securities pursuant and/or traceable to the Company' Registration Statement and Prospectus issued in relation to the Initial Public Offering on or about August 21, 2013, or on the open market between August 22, 2013 and July 2, 2014.

The complaint alleges that during the Class Period defendants failed to disclose that the danger and frequency of allergic reactions experienced by subjects in the REG1 Phase 3 trial were significant enough to derail the trial, and that the allergic reactions were so serious in nature and/or frequency as to likely result in a hold on the trial.

If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

Regado Biosciences, Inc RGDO Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible Regado Biosciences, Inc securities class action lawsuit. Please click the link below to submit your complaint for a free evaluation.